Amgen announces success of tender offer for Synergen.THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif.--(BUSINESS WIRE)--Dec. 22, 1994--Amgen Thursday announced that it has successfully completed its cash tender offer for the outstanding shares of common stock of Synergen, Inc. at $9.25 per share. The tender offer by Amgen's wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. expired at midnight EST EST electroshock therapy. EST abbr. electroshock therapy on Dec. 21, 1994. Amgen has been informed by the depository for the tender offer that, as of midnight EST Wednesday, Dec. 21, 1994 and based upon a preliminary count, approximately 91 percent of the outstanding shares of common stock of Synergen had been tendered and not withdrawn. Amgen has accepted and will pay for, in accordance with the terms of the offer, all of the shares validly tendered. As previously announced, any shares of Synergen's common stock not tendered and purchased pursuant to the offer will be acquired in a subsequent merger transaction at the same $9.25 per share cash price. It is anticipated that the merger will be effected as promptly as possible. Amgen (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMGN) is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advanced cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller . CONTACT: Amgen Inc.
David Kaye, 805/447-6692 (Media)
Sarah H. Crampton, 805/447-1659 (IR)
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion